Antibody persistence and Haemophilus influenzae type b
carriage after infant immunisation with PRP-T.
Table 6 4: Worldwide (By Geographic Region) - Number of Haemophilus Influenzae Type B
Meningitis Cases (Number), 2001 - 2011
HibTITER(R) Haemophilus b Conjugate Vaccine (Diphtheria CRM197 Protein Conjugate), the first Haemophilus influenzae type b
vaccine licensed for infants;
Results of Haemophilus influenzae type b
(Hib) rapid assessment tool (meningitis incidence rate method) in 11 developing countries Country % culture- Unadjusted Adjusted confirmed Hib meningitis Hib meningitis rate (b) rate (c) Ghana NA 0 72 (e) Uganda 50 44 59 Egypt 50 1 23 Iran 67 5 7 Jordan 43 6 14 Morocco 44 6 23 Oman 43 (f) 27 41 Yemen NA 0 23 (f) Kyrgyzstan 33 15 20 Uzbekistan NA 0 4 (g) Bhutan 42 6 15 Country Meningitis Pneumonia cases/ cases/ deaths (d) deaths (d) Ghana 2,030/609 10,148/2,030 Uganda 2,533/633 12,663/759 Egypt 1,795/682 8,977/539 Iran 599/12 2,994/180 Jordan 107/5 534/27 Morocco 689/34 3,443/172 Oman 112/11 560/34 Yemen 790/245 3,950/897 Kyrgyzstan 101/12 505/51 Uzbekistan 103/12 515/52 Bhutan 16/5 80/8 (a) Meningitis caused by Hib.
Results of microbiologic tests of specimens from five case-patients with Haemophilus influenzae type b
(a) Antimicrobial susceptibility Age/sex Latex agglutination Pen Amp Cefot test 3 months/female Positive R R S 5 months/male Positive R R S 6 months/male Positive R R S 1 year/male Positive R R S 3 years/male Positive R S S Antimicrobial susceptibility Age/sex Chl Genta [beta]-lactamase 3 months/female S S Positive 5 months/male R R Positive 6 months/male S S Positive 1 year/male S S Positive 3 years/male S S Positive (a) Pen, penicillin; Amp, ampicillin; Cefot, cefotaxime; Chl, chloramphenicol; Genta, gentamicin; S, sensitive; R, resistant.
In Italy, the vaccine against Haemophilus influenzae type b
(Hib) was licensed in 1995, but vaccination is voluntary.
Pasteur Merieux's Haemophilus influenzae type b
(PRP-T) vaccine in single dosage form and in combination with other pediatric vaccines.
The Department of Vaccines and Other Biologicals within the World Health Organization (WHO) has defined several priority vaccines for accelerated introduction; they include pneumococcal, Haemophilus influenzae type b
, rotavirus, and hepatitis B.
To determine if Haemophilus influenzae type b
(Hib) and S.
Contract notice: The vaccine against haemophilus influenzae type b
Vaccination against and Resistance in Haemophilus influenzae Type b
The Haemophilus Influenzae Type b
(Hib) Vaccine Market is Forecast to Show Low Growth up until 2019: